Human IFN alpha 1 Recombinant Protein Carrier-Free
Also known as: Interferon-alpha1, IFN-a1
RUO: For Research Use Only
Contents: Human IFN alpha 1 Recombinant Protein Carrier-Free Catalog Number: 34-8318 Formulation: Sterile liquid; phosphate buffered saline, pH 7.2, 150 mM NaCl, with no carriers or preservatives. 0.22 µm filtered. Storage Conditions: Store at less than or equal to -70°C. Handling Conditions: For best recovery, quick-spin vial prior to opening. Use in sterile envrioment. Source: E. coli expressed amino acids Cys 24-Asp 189 of mature human IFNα1 (accession # NM_024013). Molecular Mass: The protein is not methionylated at the N-terminal and has a predicted molecular mass of 19,386. The DTT reduced protein migrates as a 21 kDa polypeptide on SDS-PAGE and the non-reduced protein migrates as a 16 kDa polypeptide due to intramolecular disulfides. Purity: Greater than 98% as determined by SDS-PAGE Endotoxin Level: Less than 0.01 ng/ug cytokine as determined by the LAL assay. Bioactivity: The recombinant human IFN-α1 has been tested for inhibition of the cytopathic effect of EMC virus on A549 cells. The ED50 for this effect is typically below 0.3 ng/ml, corresponding to a specific activity of 3 x 106 U/mg.
Product Options
Cat. No.
Size
Price
Add Qty to Cart
34-8318-82
100 ug
34-8318-85
500 ug
Note: Several countries will continue to be supplied via distributors. Country specific prices may apply.
Flow Cytometry Product Notes: Test Sizes: To accommodate multicolor flow cytometry, eBioscience is in the process of reducing test size volumes from 20 µl to 5 µl. Please check your antibody vial for the recommended test size. Fluorochrome Replacements: eBioscience is in the process of replacing all Alexa Fluor® 647 conjugated products with eFluor® 660 conjugated products.
Description
Human IFN-α1 is a type I interferon previously known as B-cell interferon, leukocyte interferon, lymphoblast interferon, and pH2-stable interferon. IFN-α1 is one of at least 23 different known variants of IFN-α. The individual proteins have molecular masses between 19-26 kDa and consist of proteins with lengths of 156-166 and 172 amino acids. The IFN-α forms are produced by monocytes/macrophages, lymphoblastoid cells, fibroblasts, and other cell types following induction by viruses, nucleic acids, glucocorticoid hormones, and low-molecular weight substances (n-butyrate, 5-bromodeoxyuridine). Human IFN-α1 promotes antiviral, antiparasitic, and antiproliferative activities.
Applications Reported
For research use only, not for diagnostic or therapeutic use. Recombinant human IFN-α1 is biologically active.
Applications Tested
The recombinant human IFN-α1 has been tested for inhibition of the cytopathic effect of EMC virus on A549 cells. The ED50 for this effect is typically below 0.3 ng/ml, corresponding to a specific activity of 3 x 106 U/mg.
References
Nagai, T., et al. 2003. Timing of IFN-beta exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-beta-mediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation. J. Immunol. 171: 5233-43.
